7. Other Operating Income
Other operating income was comprised as shown in the following table:
|
|
|
|
|
|
|
2022 |
|
2023 |
|---|---|---|---|---|
|
|
€ million |
|
€ million |
Gains on retirements of noncurrent assets |
|
8 |
|
52 |
Reversals of impairment losses on receivables |
|
3 |
|
3 |
Reversals of unutilized provisions |
|
2 |
|
– |
Gains from derivatives |
|
1 |
|
3 |
Miscellaneous operating income |
|
131 |
|
214 |
Total |
|
145 |
|
272 |
Gains from derivatives in fiscal years 2022 and 2023 resulted from embedded derivatives.
Miscellaneous other operating income in fiscal 2023 primarily included insurance compensation from the primary insurer due to production stoppages in the amount of €75 million (previous year: €0 million) in the Performance Materials segment (conversely, see note 8 “Other Operating Expenses”) as well as business development subsidies received in China in the amount of €53 million (previous year: €71 million), mainly in the Solutions & Specialties segment. It also includes insurance premiums received amounting to €41 million (previous year: €36 million), which are reported in the “Reconciliation” category.